Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck & Co., Inc. MRK and Pfizer Inc. PFE. Merck disappointed by lowering its outlook, although sell-side stayed positive on the prospects.
Presentations at the American Association of Cancer Research Virtual Conference created some volatility. Verastem Inc VSTM became a casualty of "not-so-impressive" clinical data on its Phase 1 asset VS-6766 that targets KRAS mutant advanced solid tumors. The stock shed about 57% to a low of $1.77 before recovering some lost ground.
Here are the key catalysts for the unfolding week.
Conferences
SunTrust Robinson Humphrey 6th Annual Life Sciences Summit (Virtual Conference): May 5–6
Maxim Group M-Vest Infectious Disease Virtual Conference: May 5
Related Link: A Deep Dive On Coronavirus Vaccine Plays Moderna, Inovio
Clinical Readouts
Adverum Biotechnologies Inc ADVM is scheduled to present new data from the OPTIC Phase1 clinical trial of ADVM-022 intravitreal gene therapy in wet age-related macular degeneration. The call discussing the results is scheduled for Monday afternoon.
Auris Medical Holding Ltd EARS is due to release top-line data from the completed Phase 1b AM-201 trial in early May. AM-201 is being evaluated in antipsychotic-induced weight gain.
Early Q2 Schedule
Ovid Therapeutics Inc OVID: Phase 2 top-line data for OV101 in Fragile X syndrome
Iterum Therapeutics PLC ITRM: Phase 3 data for Sulopenem in uncomplicated and complicated urinary tract infections
Enanta Pharmaceuticals Inc ENTA: data from our INTREPID study of EDP-305 in patients with primary biliary cholangitis
Earnings
Monday
• Marinus Pharmaceuticals Inc MRNS (before the market open)
• Minerva Neurosciences Inc NERV (before the market open)
• Epizyme Inc EPZM (before the market open)
• SI-Bone Inc SIBN (after the market close)
• Corcept Therapeutics Incorporated CORT (after the market close)
• Chembio Diagnostics Inc CEMI (after the market close)
• GenMark Diagnostics, Inc GNMK (after the market close)
• Kura Oncology Inc KURA (after the market close)
• Varian Medical Systems, Inc. VAR (after the market close)
• Fulgent Genetics Inc FLGT (after the market close)
See Also: Inovio Analysts Project About 24% Upside Potential Amid Optimism On Coronavirus DNA Vaccine
Tuesday
• Oxford Immunotec Global PLC OXFD (before the market open)
• Karyopharm Therapeutics Inc KPTI (before the market open)
• Haemonetics Corporation HAE (before the market open)
• Antares Pharma Inc ATRS (before the market open)
• Harvard Bioscience, Inc. HBIO (before the market open)
• Vericel Corp VCEL (before the market open)
• Regeneron Pharmaceuticals Inc REGN (before the market open)
• Neuronetics Inc STIM (before the market open)
• Mallinckrodt PLC MNK (before the market open)
• Akebia Therapeutics Inc AKBA (before the market open)
• Agile Therapeutics Inc AGRX (after the market close)
• Aquestive Therapeutics Inc AQST (after the market close)
• Akcea Therapeutics Inc AKCA (after the market close)
• Acorda Therapeutics Inc ACOR (after the market close)
• Axonics Modulation Technologies Inc AXNX (after the market close)
• Synthetic Biologics Inc SYN (after the market close)
• T2 Biosystems Inc TTOO (after the market close)
• Iovance Biotherapeutics Inc IOVA (after the market close)
• MacroGenics Inc MGNX (after the market close)
• Zogenix, Inc. ZGNX (after the market close)
• Jazz Pharmaceuticals PLC JAZZ (after the market close)
• Exelixis, Inc. EXEL (after the market close)
• Myriad Genetics, Inc. MYGN (after the market close)
• Inspire Medical Systems Inc INSP (after the market close)
• Rigel Pharmaceuticals, Inc. RIGL (after the market close)
• Supernus Pharmaceuticals Inc SUPN (after the market close)
• Nevro Corp NVRO (after the market close)
• Clovis Oncology Inc CLVS (after the market close)
• InVitae Corp NVTA (after the market close)
• Cytosorbents Corp CTSO (after the market close)
• Cardiovascular Systems Inc CSII (after the market close)
• Cerus Corporation CERS (after the market close)
• Deciphera Pharmaceuticals Inc DCPH (after the market close)
• Incyte Corporation INCY (after the market close)
• Orthopediatrics Corp KIDS (after the market close)
Wednesday
• Eyepoint Pharmaceuticals Inc EYPT (before the market open)
• Horizon Therapeutics PLC HZNP (before the market open)
• Constellation Pharmaceuticals Inc CNST (before the market open)
• Alnylam Pharmaceuticals, Inc. ALNY (before the market open)
• IVERIC bio Inc ISEE (before the market open)
• Blueprint Medicines Corp BPMC (before the market open)
• BioCryst Pharmaceuticals, Inc. BCRX (before the market open)
• Strongbridge Biopharma plc SBBP (before the market open)
• Evofem Biosciences, Inc. EVFM (before the market open)
• Neurocrine Biosciences, Inc. NBIX (before the market open)
• Jounce Therapeutics Inc JNCE (before the market open)
• PPD Inc PPD (before the market open)
• Zoetis Inc ZTS (before the market open)
• Ionis Pharmaceuticals Inc IONS (before the market open)
• TherapeuticsMD Inc TXMD (before the market open)
• Avanos Medical Inc AVNS (before the market open)
• Aerie Pharmaceuticals Inc AERI (after the close)
• Allogene Therapeutics Inc ALLO (after the close)
• ADMA Biologics Inc ADMA (after the close)
• Alexion Pharmaceuticals, Inc. ALXN (after the close)
• AxoGen, Inc Common Stock AXGN (after the close)
• Global Blood Therapeutics Inc GBT (after the close)
• Pacific Biosciences of California PACB (after the close)
• Theravance Biopharma Inc TBPH (after the close)
• BioTelemetry Inc BEAT (after the close)
• Bio-Rad Laboratories, Inc. BIO (after the close)
• Veracyte Inc VCYT (after the close)
• Ligand Pharmaceuticals Inc. LGND (after the close)
• Precigen Inc PGEN (after the close)
• Ironwood Pharmaceuticals, Inc. IRWD (after the close)
• OraSure Technologies, Inc. OSUR (after the close)
• NuVasive, Inc. NUVA (after the close)
• Sarepta Therapeutics Inc SRPT (after the close)
• Natera Inc NTRA (after the close)
• Vanda Pharmaceuticals Inc. VNDA (after the close)
• Qiagen NV QGEN (after the close)
• Enanta Pharmaceuticals Inc ENTA (after the close)
• Esperion Therapeutics Inc ESPR (after the close)
• G1 Therapeutics Inc GTHX (after the close)
• Quidel Corporation QDEL (after the close)
• Cytokinetics, Inc. CYTK (after the close)
• MannKind Corporation MNKD (after the close)
Thursday
• Integra Lifesciences Holdings Corp IART (before the market open)
• Intra-Cellular Therapies Inc ITCI (before the market open)
• Endo International PLC ENDP (before the market open)
• Xeris Pharmaceuticals Inc XERS (before the market open)
• Moderna Inc MRNA (before the market open)
• Syros Pharmaceuticals Inc SYRS (before the market open)
• Elanco Animal Health Inc ELAN (before the market open)
• Athenex Inc ATNX (before the market open)
• Aldeyra Therapeutics Inc ALDX (before the market open)
• Albireo Pharma Inc ALBO (before the market open)
• ANI Pharmaceuticals Inc ANIP (before the market open)
• Agenus Inc AGEN (before the market open)
• Amicus Therapeutics, Inc. FOLD (before the market open)
• Brainstorm Cell Therapeutics Inc BCLI (before the market open)
• Bristol-Myers Squibb Co BMY (before the market open)
• Progenics Pharmaceuticals, Inc. PGNX (before the market open)
• X4 Pharmaceuticals Inc XFOR (before the market open)
• Miragen Therapeutics Inc MGEN (before the market open)
• Kala Pharmaceuticals Inc KALA (before the market open)
• Seres Therapeutics Inc MCRB (before the market open)
• Intellia Therapeutics Inc NTLA (before the market open)
• Momenta Pharmaceuticals, Inc. MNTA (before the market open)
• Editas Medicine Inc EDIT (before the market open)
• Pacira Biosciences Inc PCRX (before the market open)
• Syndax Pharmaceuticals Inc SNDX (after the close)
• Tricida Inc TCDA (after the close)
• Helius Medical Technologies Inc HSDT (after the close)
• Twist Bioscience Corp TWST (after the close)
• Athersys Inc ATHX (after the close)
• Accelerate Diagnostics Inc AXDX (after the close)
• Adamas Pharmaceuticals Inc ADMS (after the close)
• Arena Pharmaceuticals, Inc. ARNA (after the close)
• Anika Therapeutics Inc ANIK (after the close)
• Arrowhead Pharmaceuticals Inc ARWR (after the close)
• ACADIA Pharmaceuticals Inc. ACAD (after the close)
• Calithera Biosciences Inc CALA (after the close)
• BioDelivery Sciences International, Inc. BDSI (after the close)
• Puma Biotechnology Inc PBYI (after the close)
• Coherus Biosciences Inc CHRS (after the close)
• Kindred Biosciences Inc KIN (after the close)
• PDL BioPharma Inc PDLI (after the close)
• Rockwell Medical Inc RMTI (after the close)
• Penumbra Inc PEN (after the close)
• Pfenex Inc PFNX (after the close)
• ZIOPHARM Oncology Inc. ZIOP (after the close)
• NovaBay Pharmaceuticals, Inc. NBY (after the close)
• ICU Medical Inc ICUI (after the close)
• Nektar Therapeutics NKTR (after the close)
• Savara Inc SVRA (after the close)
• Sunesis Pharmaceuticals, Inc. SNSS (after the close)
• OptiNose Inc OPTN (after the close)
• Eloxx Pharmaceuticals Inc ELOX (after the close)
• Five Prime Therapeutics Inc FPRX (after the close)
• Flexion Therapeutics Inc FLXN (after the close)
• FibroGen Inc FGEN (after the close)
• Globus Medical Inc GMED (after the close)
• Guardant Health Inc GH (after the close)
• OpGen Inc OPGN (after the close)
• Lineage Cell Therapeutics Inc LCTX (after the close)
• Dynavax Technologies Corporation DVAX (after the close)
• Chiasma Inc CHMA (after the close)
• Collegium Pharmaceutical Inc COLL (after the close)
• Dicerna Pharmaceuticals Inc DRNA (after the close)
• Caladrius Biosciences Inc CLBS (after the close)
• Glaukos Corp GKOS (after the close)
• Celcuity Inc CELC (after the close)
• Codexis, Inc. CDXS (after the close)
• CytomX Therapeutics Inc CTMX (after the close)
• Insulet Corporation PODD (after the close)
Friday
• Meridian Bioscience, Inc. VIVO (before the market open)
• Mersana Therapeutics Inc MRSN (before the market open)
• Ocular Therapeutix Inc OCUL (before the market open)
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
